HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgical combination therapy for vitiligo and piebaldism.

AbstractBACKGROUND:
Refractory and stable defects of vitiligo and piebaldism may be unresponsive to medical therapy. Melanocyte transplantation can restore the normal pigmentation in some selected patients.
OBJECTIVES:
To evaluate the efficacy of additional mini-grafting with 1.0-1.2-mm punch grafts to complete the restoration of achromic defects when performing surgical correction of leukoderma.
METHODS:
Eight patients with refractory stable leukoderma were treated with melanocyte transplantation; three with segmental vitiligo had epidermal shave, by removing the hyperpigmented macules at the periphery of achromic lesions; two others received suction epidermal grafts; and three subjects were treated by in vitro cultured epidermal autografts. All patients received additional mini-grafts in areas of residual achromia.
RESULTS:
The depigmented defects were 100% restored in seven patients, and in one subject 80% improvement was observed.
CONCLUSION:
Surgical methods, followed by additional mini-grafting, may be helpful to restore completely the depigmented defects when residual achromia, after treatment with the methods described above, is still present.
AuthorsR Falabella, M Barona, C Escobar, I Borrero, A Arrunategui
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (Dermatol Surg) Vol. 21 Issue 10 Pg. 852-7 (Oct 1995) ISSN: 1076-0512 [Print] United States
PMID7551740 (Publication Type: Journal Article)
Topics
  • Cells, Cultured
  • Combined Modality Therapy
  • Epidermis (surgery, transplantation)
  • Esthetics
  • Humans
  • Melanocytes (transplantation)
  • Piebaldism (surgery)
  • Skin Transplantation (methods)
  • Transplantation, Autologous
  • Vitiligo (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: